Loading stock…

Amplifon S.p.A. (AMP) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

AMPAmplifon S.p.A.

Revenue FY25$2.8B

GROWTH RATING↗

STRONG68 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+7%6

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+11%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+57%9

EPS growth, FY27E+64%10

EPS growth, FY28E+12%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 68% of companies worldwide.

Revenue grew 7%/yr over the last 3 years and is set to grow 15%/yr from here.

The runway holds up: revenue is set to grow 11%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 57%/yr vs revenue 15%/yr), so margins should widen.

WATCH

Revenue is set to grow 15%/yr over the next 3 years, a little ahead of the market.6/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

AMPAmplifon S.p.A.

Total return Current53.3%

Price return Current42.3%

MOMENTUM RATING↗

AVERAGE37 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+4%9

3-month return+17%9

YTD return-10%3

MID & LONG-TERM▾SCORE

% of 52-week high79%5

1-year return-18%3

3-year return-53%1

5-year return-69%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+4%) and over three months (+17%).

WATCH

It's down 18% over the past year, now 21% below its 52-week high. That is a touch behind the market.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-53% over three years and -69% over five), behind 90% of the market.

The stock is underperforming so far this year (-10%).

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Amplifon. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

AMPAmplifon S.p.A.

Revenue FY25$2.8B

GROWTH RATING↗

STRONG68 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+7%6

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+11%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+57%9

EPS growth, FY27E+64%10

EPS growth, FY28E+12%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 68% of companies worldwide.

Revenue grew 7%/yr over the last 3 years and is set to grow 15%/yr from here.

The runway holds up: revenue is set to grow 11%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 57%/yr vs revenue 15%/yr), so margins should widen.

WATCH

Revenue is set to grow 15%/yr over the next 3 years, a little ahead of the market.6/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

AMPAmplifon S.p.A.

Total return Current53.3%

Price return Current42.3%

MOMENTUM RATING↗

AVERAGE37 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+4%9

3-month return+17%9

YTD return-10%3

MID & LONG-TERM▾SCORE

% of 52-week high79%5

1-year return-18%3

3-year return-53%1

5-year return-69%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+4%) and over three months (+17%).

WATCH

It's down 18% over the past year, now 21% below its 52-week high. That is a touch behind the market.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-53% over three years and -69% over five), behind 90% of the market.

The stock is underperforming so far this year (-10%).

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Amplifon. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Amplifon S.p.A.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Amplifon. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Amplifon. Get the full investment case.

Premium